Investigating the attitude of patients with chronic diseases about using mobile health

2020 ◽  
Vol 36 (2) ◽  
pp. 139-144 ◽  
Author(s):  
Reza Abbasi ◽  
Sahar Zare ◽  
Leila Ahmadian

BackgroundMobile health (mHealth) due to its popularity and accessibility can be widely applied in different health areas such as the management of chronic diseases. However, its success depends on the acceptance of their users. Therefore, the aim of this study was to survey the attitudes of patients with chronic disease toward mHealth technology and their willingness to use it.MethodsThis study was conducted within a 2-year period (2016–2018) to determine and compare the attitude and willingness of patients with asthma, diabetes, and multiple sclerosis (MS) toward using mHealth technology in a province in Iran.ResultsIn total, 222 patients participated in this study. More than 93 percent of the patients with diabetes and MS, and 65 percent of the asthmatic patients preferred using mHealth services rather than consulting a physician (p < .0001). About 98, 94, and 49 percent of the MS, diabetic, and asthmatic patients, respectively felt comfortable if their health conditions checked by physicians through mHealth technology (p < .0001).ConclusionsOur results showed that the majority of the patients felt comfortable and preferred using mHealth technology rather than consulting the physicians. The attitudes of diabetic and MS patients toward mHealth technology were rather more positive compared to asthmatic patient attitude. These results may be helpful for the developers of mHealth technology, and researchers who design mHelath interventions for patients with chronic disease.

Author(s):  
Petre Iltchev ◽  
Andrzej Śliwczyński ◽  
Potr Szynkiewicz ◽  
Michał Marczak

This chapter analyzes the role of m-health applications supporting patients with chronic diseases (based on examples from asthma care). The purpose of the chapter is to describe the mobile health application development cycle. The chapter begins with a presentation of asthma as a chronic disease and its prevalence and costs for society, as a determinant of the role and place of m-health applications in chronic disease management. Subsequent sections analyze trends in the development of health care, information systems, and health care payment systems as components of the environment for the implementation of m-health applications. The chapter focuses on prerequisites for the introduction of this type of solutions, presents existing applications, and discusses how to define the key functionalities and benefits for patients, payers, and doctors. The financing cycle, barriers to implementation, and future trends are also addressed.


Author(s):  
Petre Iltchev ◽  
Andrzej Śliwczyński ◽  
Potr Szynkiewicz ◽  
Michał Marczak

This chapter analyzes the role of m-health applications supporting patients with chronic diseases (based on examples from asthma care). The purpose of the chapter is to describe the mobile health application development cycle. The chapter begins with a presentation of asthma as a chronic disease and its prevalence and costs for society, as a determinant of the role and place of m-health applications in chronic disease management. Subsequent sections analyze trends in the development of health care, information systems, and health care payment systems as components of the environment for the implementation of m-health applications. The chapter focuses on prerequisites for the introduction of this type of solutions, presents existing applications, and discusses how to define the key functionalities and benefits for patients, payers, and doctors. The financing cycle, barriers to implementation, and future trends are also addressed.


JAMIA Open ◽  
2020 ◽  
Author(s):  
Elizabeth S Gromisch ◽  
Aaron P Turner ◽  
Jodie K Haselkorn ◽  
Albert C Lo ◽  
Thomas Agresta

Abstract Objectives Persons with multiple sclerosis (MS) can face a number of potential healthcare-related barriers, for which mobile health (mHealth) technology can be potentially beneficial. This review aimed to understand the frequency, current uses, and potential barriers with mHealth usage among persons with MS. Methods A query string was used to identify articles on PubMed, MEDLINE, CINAHL, and IEEE Xplore that were published in English between January 2010 and December 2019. Abstracts were reviewed and selected based on a priori inclusion and exclusion criteria. Fifty-nine peer-reviewed research studies related to the study questions are summarized. Results The majority of persons with MS were reported as using smartphones, although rates of mHealth utilization varied widely. mHealth usage was grouped into 3 broad categories: (1) disability and symptom measurement; (2) interventions and symptom management; and (3) tracking and promoting adherence. While there have been an increasing number of mHealth options, certain limitations associated with MS (eg, poor dexterity, memory problems) may affect usage, although including persons with MS in the design process can address some of these issues. Discussion Given the increased attention to mHealth in this population and the current need for telehealth and at home devices, it is important that persons with MS and healthcare providers are involved in the development of new mHealth tools to ensure that the end product meets their needs. Considerations for addressing the potential mHealth use barriers in persons with MS are discussed.


2019 ◽  
Vol 2019 ◽  
pp. 1-7
Author(s):  
Fanbo Meng ◽  
Xiaofei Zhang ◽  
Xitong Guo ◽  
Kee-hung Lai ◽  
Xinli Zhao

Objectives. The increasing population of patients with chronic diseases generates great challenge of chronic disease management. The occurrence of mobile health monitoring service (MHMS) is beneficial to chronic disease prevention and health promotion. The objective of this study is to investigate how patients with chronic diseases make usage decisions on MHMS. Study Design. A survey. Methods. 213 respondents with chronic diseases were asked to rate their level of health severity, negative health emotions, and health uncertainty avoidance. SmartPLS was used to test the measurement model. Results. Of 213 research respondents, 159 of them have one chronic disease, while 54 have more than one such disease. Perceived health severity of patients with chronic diseases positively influences MHMS usage intentions, while negative health emotions do not. Health uncertainty avoidance strengthens the effect of health severity but weakens the effect of negative health emotions on MHMS usage intentions. Conclusion. Patients with chronic diseases have a unique decision-making process regarding MHMS usage in which their special health-related factors and tendencies play a critical role in determining behavioral intentions.


2019 ◽  
pp. 1076-1103
Author(s):  
Petre Iltchev ◽  
Andrzej Śliwczyński ◽  
Potr Szynkiewicz ◽  
Michał Marczak

This chapter analyzes the role of m-health applications supporting patients with chronic diseases (based on examples from asthma care). The purpose of the chapter is to describe the mobile health application development cycle. The chapter begins with a presentation of asthma as a chronic disease and its prevalence and costs for society, as a determinant of the role and place of m-health applications in chronic disease management. Subsequent sections analyze trends in the development of health care, information systems, and health care payment systems as components of the environment for the implementation of m-health applications. The chapter focuses on prerequisites for the introduction of this type of solutions, presents existing applications, and discusses how to define the key functionalities and benefits for patients, payers, and doctors. The financing cycle, barriers to implementation, and future trends are also addressed.


2020 ◽  
pp. 135245852095967
Author(s):  
Magnus Spangsberg Boesen ◽  
Morten Blinkenberg ◽  
Lau Caspar Thygesen ◽  
Frank Eriksson ◽  
Melinda Magyari

Background: Pediatric multiple sclerosis (MS) may hamper educational achievements due to psychiatric comorbidity and cognitive impairment. Our aims were to investigate school performance, psychiatric comorbidity, and healthcare utilization following pediatric MS and to differentiate between disability in MS and that arising from a non-brain-related chronic disease. Methods: We included all children (<18 years) with MS onset during 2008–2015 in Denmark with a medical record–validated MS diagnosis. The control groups were children from the general population or children with non-brain-related chronic diseases. Outcomes were register-based on 9–12 grade point average, psychiatric comorbidity, and healthcare visits. Results: Cohorts were children with MS ( n = 92), control children matched to children with MS ( n = 920), children with non-brain-related chronic diseases ( n = 9108), and “healthy” children with neither MS nor brain-related chronic disease ( n = 811,464). School performance in grades 9–12 was similar, but children with MS compared to those with non-brain-related chronic disease had an almost doubled hazard for psychiatric comorbidity (hazard ratio = 1.87; 95% confidence interval = 1.38–2.53; p < 0.0001) and a higher rate of all hospital visits ( p < 0.0001) but a lower rate of hospital admissions ( p = 0.001). Conclusion: Children with MS have a seemingly standard school performance but increased psychiatric comorbidity and a high rate of healthcare utilization.


2020 ◽  
Vol 83 (9) ◽  
pp. 561-575
Author(s):  
Janine F Farragher ◽  
Sarbjit V Jassal ◽  
Sara McEwen ◽  
Helene J Polatajko

Introduction Fatigue is a pervasive symptom of chronic disease that often interferes with occupational performance. Our objective was to describe what is known about energy management education and occupation-related outcomes in adults with chronic diseases. Methods Seven electronic databases were searched for relevant literature published before August 2019. Eligible articles were full-text, available in English, and studied energy management education in adults with a chronic disease. The first author assessed article eligibility with validation from a second reviewer, extracted characteristics of included studies, and described them using descriptive statistics. A narrative synthesis of findings was conducted for each chronic disease population. Results Forty-four studies addressed eight different chronic disease populations. The most common program delivery format was face-to-face in a group setting (42%), 39% of programs were informed by a learning theory, and their median cumulative length was 8 hours. Positive outcomes were associated with a specific, group-based energy management program in people with multiple sclerosis. The evidence on other energy management programs and in other chronic disease populations was more limited and inconclusive. Conclusions Further research is needed to understand the impact of energy management education in chronic disease populations beyond multiple sclerosis, and its impact on occupational performance.


2021 ◽  
Vol 12 ◽  
Author(s):  
Emma L. Connolly ◽  
Marc Sim ◽  
Nikolaj Travica ◽  
Wolfgang Marx ◽  
Gemma Beasy ◽  
...  

An increasing body of evidence highlights the strong potential for a diet rich in fruit and vegetables to delay, and often prevent, the onset of chronic diseases, including cardiometabolic, neurological, and musculoskeletal conditions, and certain cancers. A possible protective component, glucosinolates, which are phytochemicals found almost exclusively in cruciferous vegetables, have been identified from preclinical and clinical studies. Current research suggests that glucosinolates (and isothiocyanates) act via several mechanisms, ultimately exhibiting anti-inflammatory, antioxidant, and chemo-protective effects. This review summarizes the current knowledge surrounding cruciferous vegetables and their glucosinolates in relation to the specified health conditions. Although there is evidence that consumption of a high glucosinolate diet is linked with reduced incidence of chronic diseases, future large-scale placebo-controlled human trials including standardized glucosinolate supplements are needed.


2018 ◽  
Vol 7 (1) ◽  
pp. 22-24
Author(s):  
Darlene Zimmerman

ABSTRACT The 2015 – 2020 Dietary Guidelines for Americans provides guidance for choosing a healthy diet. There is a focus on preventing and alleviating the effects of diet-related chronic diseases. These include obesity, diabetes, cardiovascular disease, and stroke, among others. This article briefly reviews the primary guideline items that can be used to teach patients with respect to improving their diet. Clinical exercise physiologists who work with patients with chronic disease can use these guidelines for general discussions regarding a heart-healthy diet.


Sign in / Sign up

Export Citation Format

Share Document